These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 23009111)

  • 21. B-cell lymphomas differ in their responsiveness to CpG oligodeoxynucleotides.
    Jahrsdorfer B; Mühlenhoff L; Blackwell SE; Wagner M; Poeck H; Hartmann E; Jox R; Giese T; Emmerich B; Endres S; Weiner GJ; Hartmann G
    Clin Cancer Res; 2005 Feb; 11(4):1490-9. PubMed ID: 15746051
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional TLR9 modulates bone marrow B cells from rheumatoid arthritis patients.
    Rudnicka W; Burakowski T; Warnawin E; Jastrzebska M; Bik M; Kontny E; Chorazy-Massalska M; Radzikowska A; Buler M; Maldyk P; Maslinski W
    Eur J Immunol; 2009 May; 39(5):1211-20. PubMed ID: 19384869
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Activation and clinicopathologic significance of AKT/mTOR signaling pathway in diffuse large B-cell lymphoma].
    Yu BH; Zhou XY; Xiao XY; Yan SY; Qin T; Shi DR
    Zhonghua Bing Li Xue Za Zhi; 2009 Jan; 38(1):35-41. PubMed ID: 19489223
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TLR4- and TLR9-dependent effects on cytokines, cell viability, and invasion in human bladder cancer cells.
    Olbert PJ; Kesch C; Henrici M; Subtil FS; Honacker A; Hegele A; Hofmann R; Hänze J
    Urol Oncol; 2015 Mar; 33(3):110.e19-27. PubMed ID: 25499923
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CpG oligonucleotide activates Toll-like receptor 9 and causes lung inflammation in vivo.
    Knuefermann P; Baumgarten G; Koch A; Schwederski M; Velten M; Ehrentraut H; Mersmann J; Meyer R; Hoeft A; Zacharowski K; Grohé C
    Respir Res; 2007 Oct; 8(1):72. PubMed ID: 17925007
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The activation of liver X receptors inhibits toll-like receptor-9-induced foam cell formation.
    Sorrentino R; Morello S; Chen S; Bonavita E; Pinto A
    J Cell Physiol; 2010 Apr; 223(1):158-67. PubMed ID: 20049870
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chloroquine inhibits MGC803 gastric cancer cell migration via the Toll-like receptor 9/nuclear factor kappa B signaling pathway.
    Zhang Y; Li Y; Li Y; Li R; Ma Y; Wang H; Wang Y
    Mol Med Rep; 2015 Feb; 11(2):1366-71. PubMed ID: 25369757
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impaired toll-like receptor 9 expression in alveolar macrophages with no sensitivity to CpG DNA.
    Suzuki K; Suda T; Naito T; Ide K; Chida K; Nakamura H
    Am J Respir Crit Care Med; 2005 Apr; 171(7):707-13. PubMed ID: 15640365
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CpG-oligodeoxynucleotide-induced TLR9 activation regulates macrophage TREM-1 expression and shedding.
    Molad Y; Pokroy-Shapira E; Carmon V
    Innate Immun; 2013 Dec; 19(6):623-30. PubMed ID: 23475790
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential contribution of osteoclast- and osteoblast-lineage cells to CpG-oligodeoxynucleotide (CpG-ODN) modulation of osteoclastogenesis.
    Amcheslavsky A; Hemmi H; Akira S; Bar-Shavit Z
    J Bone Miner Res; 2005 Sep; 20(9):1692-9. PubMed ID: 16059640
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cross-talk between toll-like receptors 5 and 9 on activation of human immune responses.
    Merlo A; Calcaterra C; Mènard S; Balsari A
    J Leukoc Biol; 2007 Sep; 82(3):509-18. PubMed ID: 17586660
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Heterozygous carriage of a dysfunctional Toll-like receptor 9 allele affects CpG oligonucleotide responses in B cells.
    Knezević J; Pavlinić D; Rose WA; Leifer CA; Bendelja K; Gabrilovac J; Parcina M; Lauc G; Kubarenko AV; Petricevic B; Vrbanec D; Bulat-Kardum L; Bekeredjian-Ding I; Pavelić J; Dembić Z; Weber AN
    J Biol Chem; 2012 Jul; 287(29):24544-53. PubMed ID: 22613717
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The human Burkitt lymphoma cell line Namalwa represents a homogenous cell system characterized by high levels of Toll-like receptor 9 and activation by CpG oligonucleotides.
    Henault M; Lee LN; Evans GF; Zuckerman SH
    J Immunol Methods; 2005 May; 300(1-2):93-9. PubMed ID: 15894327
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CpG ODN-induced matrix metalloproteinase-13 expression is mediated via activation of the ERK and NF-κB signalling pathways in odontoblast cells.
    Zhang J; Zhu QL; Huang P; Yu Q; Wang ZH; Cooper PR; Smith AJ; He W
    Int Endod J; 2013 Jul; 46(7):666-74. PubMed ID: 23331101
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TLR9 expression in glioma tissues correlated to glioma progression and the prognosis of GBM patients.
    Wang C; Cao S; Yan Y; Ying Q; Jiang T; Xu K; Wu A
    BMC Cancer; 2010 Aug; 10():415. PubMed ID: 20696081
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of modifications of heterocyclic bases in CpG dinucleotides on their immune-modulatory activity.
    Vollmer J; Weeratna RD; Jurk M; Davis HL; Schetter C; Wüllner M; Wader T; Liu M; Kritzler A; Krieg AM
    J Leukoc Biol; 2004 Sep; 76(3):585-93. PubMed ID: 15218053
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cpg-ODN, a TLR9 Agonist, Aggravates Myocardial Ischemia/Reperfusion Injury by Activation of TLR9-P38 MAPK Signaling.
    Xie L; He S; Kong N; Zhu Y; Tang Y; Li J; Liu Z; Liu J; Gong J
    Cell Physiol Biochem; 2018; 47(4):1389-1398. PubMed ID: 29929196
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The immunostimulatory effect of CpG oligodeoxynucleotides on peripheral blood mononuclear cells of healthy dogs and dogs with atopic dermatitis.
    Jassies-van der Lee A; Rutten V; Spiering R; van Kooten P; Willemse T; Broere F
    Vet J; 2014 Apr; 200(1):103-8. PubMed ID: 24461202
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CpG-oligodeoxynucleotide inhibits Smad-dependent bone morphogenetic protein signaling: effects on myeloma cell apoptosis and in vitro osteoblastogenesis.
    Nørgaard NN; Holien T; Jönsson S; Hella H; Espevik T; Sundan A; Standal T
    J Immunol; 2010 Sep; 185(6):3131-9. PubMed ID: 20702733
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antimalarial artesunate protects sepsis model mice against heat-killed Escherichia coli challenge by decreasing TLR4, TLR9 mRNA expressions and transcription factor NF-kappa B activation.
    Li B; Zhang R; Li J; Zhang L; Ding G; Luo P; He S; Dong Y; Jiang W; Lu Y; Cao H; Zheng J; Zhou H
    Int Immunopharmacol; 2008 Mar; 8(3):379-89. PubMed ID: 18279792
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.